Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

The pilot is a significant departure from the current model, which gives hospitals upfront discounts for some drugs.

Stocks capped a choppy day of trading on Wall Street with more losses Thursday after an early big tech rally faded and a ...

The FDA issued a complete response letter for Regeneron's lymphoma drug odronextamab. Elsewhere, Bristol Myers raised its guidance and analysts saw progress in Biogen’s turnaround.

BioNTech (NASDAQ:BNTX) is scheduled to announce Q2 earnings results on Monday, August 4th, before market open. The consensus EPS Estimate is -$1.65 (+50.9% Y/Y) and the consensus Revenue Estimate is ...